Depression is associated with decreased prefrontal thickness and hippocampal volume; some evidence suggests this may also apply to subclinical depression. With increasing age, brain volume decreases, mainly grey matter volume. Less is known about these associations in the general population and across the lifespan since most studies on depression have limited age ranges.
Ms Julia Binnewies (University of Groningen, the Netherlands) and colleagues analysed possible associations between (sub)clinical depression and brain structure, including potential effects of age and sex on these associations. Enrolled were 3,447 participants from 8 cohorts of the European Lifebrain Consortium: 5 were general population cohorts and 2 included patients with depression and healthy controls. Measured outcomes were the thickness of rostral anterior cingulate cortex (rACC), medial orbitofrontal cortex (mOFC), and hippocampal volume. Depression based on several depression scales served as a predictor, resulting in continuous depressive symptoms and dichotomous depression status.
The total cohort comprised 3,428 subjects, 540 (15.7%) of whom met the criteria for mild-to-severe depression: 287 (9.5%) in the general population cohort, 253 (62.1%) in the patient-control cohorts. Within this group, 262 met the criteria for moderate-to-severe depression. Across all cohorts and across general population cohorts, there were no associations between depression symptom severity or depression status with any of the brain measures. In the 2 clinical patient-control cohorts, depression symptom severity was associated with lower mOFC thickness (r=-0.13), rACC thickness (r=-0.21), and lower hippocampal volume (r=-0.13). Depression was associated with lower mOFC thickness (r=-0.08). There were no indications of age-dependent effects. The authors concluded that their findings illustrate structural brain changes are mainly limited to clinically depressed patients and are rather modest.
- Binnewies J. Associations between depression and brain structure across the lifespan: results from the European Lifebrain Consortium. S.10.01, ECNP 2021 Congress, 2–5 October.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« BDNF/TrkB pathway promising alternative for new antidepressants Next Article
Letter from the Editor »
« BDNF/TrkB pathway promising alternative for new antidepressants Next Article
Letter from the Editor »
Table of Contents: ECNP 2021
Featured articles
Anxiety and Stress
Anxiolytic activity of a novel orexin-1 receptor antagonist
Autism
Finding biomarkers for improved patient stratification
Behavioural Disorders
Sex similarities and differences in the neurobiology of aggression
Risky driving and lifestyle may have a common psychobiological basis
Cannabidiol for cannabis cessation shows positive results
Somatic comorbidities of ADHD: epidemiological and genetic data
Novel approaches to understanding the social brain
COVID-19
Alcohol consumption during lockdown
Post-COVID-19 depression responds well to SSRIs
Impact of COVID-19 on patients with psychotic disorders
Mood Disorders
Depression and brain structures associations across a lifespan
BDNF/TrkB pathway promising alternative for new antidepressants
Zuranolone reduces symptoms of major depression
Vortioxetine effectively reduces symptoms of depression and anxiety
Esketamine outperforms real-world management for treatment-resistant depression: preliminary results
Smartphone interventions in bipolar disorder: a position paper
Connecting, challenging, and empowering youth through their smartphone
Personality Disorders
Evaluating vafidemstat for the treatment of borderline personality disorder
Deep brain stimulation effective in the treatment of refractory OCD
Psychotic Disorders
Why antipsychotics cause weight gain
Roluperidone improves negative symptoms in schizophrenia
Other
Brain Prize Lecture: Prof. Jes Olesen on migraine
Laxative may improve cognitive performance
Related Articles
November 26, 2021
Brain Prize Lecture: Prof. Jes Olesen on migraine
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com